Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-23

FDA Approved: MIFEPRISTONE — Supplemental Application (GenBioPro, Inc.)

View source ↗

Summary

The FDA approved GenBioPro's supplemental application for mifepristone, updating the approved labeling for the generic product. It pertains to the abortion-indu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mifepristone (mifepristone)

Snippet

SUPPL AP for MIFEPRISTONE (MIFEPRISTONE)